FACTOR V LEIDEN KIT 03610179001

MAUDE Adverse Event Report

MAUDE data represents reports of adverse events involving medical devices. This maude entry was filed from a 04 report with the FDA on 2009-04-06 for FACTOR V LEIDEN KIT 03610179001 manufactured by Roche Diagnostics Gmbh.

Event Text Entries

[1055720] Customer reported out results from two invalid lightcycler factor v leiden test runs. The runs were invalid due to failed controls. Reporting results from invalid runs risks the release of erroneous results.
Patient Sequence No: 1, Text Type: D, B5


[8183367] No investigation will be performed as there is no evidence of a product non-conformance. Review of the package insert identified the following text in the quality control section: "the assay result for the factor v leiden negative control should always be "negative". If this is not the case, the whole run is flagged as invalid. The entire procedure (specimen preparation, amplification and detection) must be repeated. If the negative control consistently gives a non-negative result, contact your local roche representative for technical assistance. " "the assay result for the factor v leiden ct should always be genotyped as "het". If this is not observed, the run is invalid and the entire procedure (specimen preparation, amplification and detection) must be repeated. If the positve control consistently fails for the heterozygous genotype, contact your local roche representative for technical assistance. " also in the expected values/interpretation of results section it states, "ensure that the control results for the run are valid. If the run is invalid, repeat the entire run (specimen preparation, amplification and detection). "
Patient Sequence No: 1, Text Type: N, H10


[15451239] Investigation into the root cause of control failures was performed. The root cause was determined to be due to the generation of supercoiling of the wildtype and mutation plasmids in the control that cause the unequal amplification results between the two and therefore, the result is interpreted as invalid. There is no medical risk associated with a failed control as the generated results are invalid and not to be reported. The primary medical treatment decision that would be based on the results of the lc factor v assay would be whether to discontinue anticoagulation after a standard 3 - 6 months or to continue anticoagulation indefinitely. Since the patient is already under treatment, there is no risk of delaying treatment from the factor v control failure that led to an invalid run. The treating clinician would continue the anticoagulation therapy until a valid factor v assay was completed. Due to low level of risk associated with a failed control, further mitigation is not being considered.
Patient Sequence No: 1, Text Type: N, H10


MAUDE Entry Details

Report Number2243471-2009-00007
MDR Report Key1355461
Report Source04
Date Received2009-04-06
Date of Report2009-04-23
Date Mfgr Received2009-03-11
Date Added to Maude2009-06-03
Event Key0
Report Source CodeManufacturer report
Manufacturer LinkY
Number of Patients in Event0
Adverse Event Flag3
Product Problem Flag3
Reprocessed and Reused Flag3
Reporter OccupationOTHER HEALTH CARE PROFESSIONAL
Health Professional3
Initial Report to FDA3
Report to FDA0
Event Location0
Manufacturer ContactMR ROBERT PIGOZZI
Manufacturer Street4300 HACIENDA DRIVE
Manufacturer CityPLEASANTON CA 945880900
Manufacturer CountryUS
Manufacturer Postal9458809008
Manufacturer Phone9257308272
Manufacturer G1ROCHE APPLIED SCIENCE
Manufacturer StreetNONNENWALD 2
Manufacturer CityPENZBERG, 82377
Manufacturer CountryGM
Manufacturer Postal Code82377
Single Use3
Previous Use Code3
Event Type3
Type of Report3

Device Details

Brand NameFACTOR V LEIDEN KIT
Generic NameFACTOR V LEIDEN MUTATION DETECTION SYSTEM
Product CodeNPQ
Date Received2009-04-06
Catalog Number03610179001
Lot Number14674120
Device Expiration Date2009-12-31
OperatorMEDICAL TECHNOLOGIST
Device AgeDA
Device Eval'ed by MfgrN
Device Sequence No1
Device Event Key0
ManufacturerROCHE DIAGNOSTICS GMBH
Manufacturer AddressNONNENWALD 2 PEMZBERG, 82377 GM 82377


Patients

Patient NumberTreatmentOutcomeDate
10 2009-04-06

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.